53 Current news about the topic molecular diagnostics

rss

Epigenetics Specialist Epivios Financed by High-Tech Gründerfonds and Life Science Inkubator´s Pre-seed Fund

16-07-2012

Start-up financers High-Tech Gründerfonds and the investment company of Life Science Inkubator are investing together with the TTHU (Technology Transfer Heinrich Heine University GmbH) and a private investor in the development of molecular diagnostic cancer tests. Epivios GmbH, a spin-off of the ...

more

Lab21 Extends CPA Accreditation

02-11-2011

Lab21 Limited has announced that its Clinical Laboratory Division has extended its Clinical Pathology Accreditation (CPA) scope to include Molecular Biology and Virology in addition to Biochemistry. The accreditation was awarded by Clinical Pathology Accreditation (UK), the quality assurance ...

more

Curetis AG attracts Forbion and Roche as new investors

Series A financing round expanded to €34.1 million

31-10-2011

Curetis AG announced the expansion of its Series A financing round by € 9.6 million. The additional funds increase the round to a total of € 34.1 million and the total capital raised to date to € 36.6 million. The financing was led by Forbion Capital Partners together with Roche Venture Fund. ...

more

Abbott Introduces New ALK Genetic Test for Specific Form of Non-Small-Cell Lung Cancer

02-09-2011

Abbott announced the availability of a new molecular test in the European Union and New Zealand designed to identify the presence of gene rearrangements associated with a specific form of non-small-cell lung cancer (NSCLC). These rearrangements in a gene known as ALK (anaplastic lymphoma kinase) ...

more

Exonhit and BGI Announce Successful Completion of a Promising Next-Generation Sequencing Project

Combining complementary platforms facilitates rapid and comprehensive discovery and development of biologically relevant markers

29-07-2011

Exonhit and BGI announced the successful completion of a project dedicated to expanding Exonhit’s Genome-Wide SpliceArrayTM to an additional strategic preclinical animal model species.To answer the need for a comprehensive understanding of gene deregulation and the expanding interest in ...

more

Analytik Jena Receives China's Most Prestigious Award of the Analytics Industry

24-05-2011

The new real-time PCR device qTower from Analytik Jena AG was honored as "One of the best new devices in 2010" at this year's Annual Conference of China Scientific Instruments (ACCSI). "This award is an important signal for us in the current phase of the market introduction of our real-time PCR ...

more

ATLAS Biolabs fulfills the DIN EN ISO 13485:2003 + AC: 2009 standard for designing and manufacturing medical devices

13-05-2011

By gaining certification according to the internationally recognized quality standard DIN EN ISO 13485 + AC:2009, ATLAS Biolabs GmbH has reached another milestone in its advances in the field of molecular diagnostics. DIN EN ISO 13485 + AC:2009 provides the criteria for quality management in the ...

more

First Patient Included in Multicenter Study to Evaluate SIRS-Lab’s Diagnostic Test for Blood-Stream Infection

24-03-2011

SIRS-Lab announced the inclusion of the first patient in a 1000-patient clinical study evaluating their molecular pathogen test VYOO. The multicenter trial, performed in 11 key centers across Germany and initiated in February 2011, will deliver data about the utility of the PCR test compared to ...

more

bioMérieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics

Co-development of assays and co-distribution of a fully integrated molecular platform due for launch in 2012

09-11-2010

bioMérieux and Biocartis announced that they have entered into a strategic agreement to co-develop assays on Biocartis’ fully integrated molecular diagnostics system, which the two companies will co-distribute starting in 2012. Under the agreement, bioMérieux will have worldwide exclusive rights ...

more

Genetic Technologies appoints Lewis J. Stuart as General Manager of its New North American Molecular Diagnostics Business

23-06-2010

Genetic Technologies Limited announced the appointment of Mr. Lewis Stuart as General Manager of its North American molecular diagnostics business. The new division is the result of the Company’s recent acquisition of US assets including BREVAGen™, a fully validated risk assessment test for ...

more

Page 1 From 6
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE